scholarly article | Q13442814 |
P50 | author | Polly Matzinger | Q3395388 |
Jacques Ravel | Q30093147 | ||
Xiaoxi Dong | Q61998704 | ||
P2093 | author name string | Amiran Dzutsev | |
Martin Schuster | |||
Andrey Morgun | |||
D Joseph Sexton | |||
Natalia Shulzhenko | |||
Renee L Greer | |||
William Hsiao | |||
P2860 | cites work | The RAST Server: rapid annotations using subsystems technology | Q21263157 |
Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation | Q22253403 | ||
Adverse Effects of Antimicrobials via Predictable or Idiosyncratic Inhibition of Host Mitochondrial Components | Q24616291 | ||
Antibiotics in early life alter the murine colonic microbiome and adiposity | Q24630877 | ||
The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes | Q24817116 | ||
Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells | Q26822643 | ||
Reverse enGENEering of Regulatory Networks from Big Data: A Roadmap for Biologists | Q28083193 | ||
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer | Q28119171 | ||
Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis | Q28266275 | ||
Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model | Q28297288 | ||
Contribution of the RsaL global regulator to Pseudomonas aeruginosa virulence and biofilm formation | Q28492725 | ||
Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences | Q29394736 | ||
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
The human microbiome: at the interface of health and disease | Q29614801 | ||
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis | Q30920058 | ||
Antibiotic side effects | Q31974254 | ||
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation | Q33420665 | ||
Relating the metatranscriptome and metagenome of the human gut. | Q33730723 | ||
Construct and Compare Gene Coexpression Networks with DAPfinder and DAPview. | Q33960783 | ||
Reverse-engineering human regulatory networks | Q34026195 | ||
The multiple signaling systems regulating virulence in Pseudomonas aeruginosa | Q34030980 | ||
Integrated microbial survey analysis of prokaryotic communities for the PhyloChip microarray | Q34055315 | ||
Principles and strategies for developing network models in cancer | Q34171479 | ||
Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis | Q34251928 | ||
Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma | Q34261744 | ||
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. | Q34360221 | ||
An archaeal origin of eukaryotes supports only two primary domains of life | Q34391778 | ||
Clinical practice. Antibiotic-associated diarrhea | Q34512995 | ||
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits | Q34596030 | ||
Microbe-Dependent and Nonspecific Effects of Procedures To Eliminate the Resident Microbiota from Drosophila melanogaster | Q34615771 | ||
Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression | Q34704203 | ||
Bridging immunity and lipid metabolism by gut microbiota | Q34887482 | ||
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. | Q35050169 | ||
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection | Q35577842 | ||
B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. | Q35784554 | ||
Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation | Q35874723 | ||
How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy | Q35903212 | ||
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia | Q36032639 | ||
Antibiotics, microbiota, and immune defense | Q36188444 | ||
Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota | Q36319423 | ||
The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis | Q36463413 | ||
Specific gut commensal flora locally alters T cell tuning to endogenous ligands | Q37108927 | ||
Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. | Q37139410 | ||
Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses | Q37267529 | ||
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut | Q37515645 | ||
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses | Q37581953 | ||
Bacterial competition: surviving and thriving in the microbial jungle | Q37641019 | ||
Physiological framework for the regulation of quorum sensing-dependent public goods in Pseudomonas aeruginosa | Q37643421 | ||
Acyl-Homoserine Lactone Quorum Sensing: From Evolution to Application | Q38107502 | ||
Intestinal microbiota, diet and health. | Q38127785 | ||
Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity | Q39025073 | ||
Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis | Q39306213 | ||
Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases | Q39519588 | ||
Antibiotic-associated colitis—A review of 66 cases | Q40019318 | ||
Antibiotic use in animal agriculture | Q41673737 | ||
Antibiotic use and inflammatory bowel diseases in childhood | Q43947206 | ||
Interactional and functional centrality in transcriptional co-expression networks | Q45215680 | ||
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota | Q46878665 | ||
Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease | Q71197864 | ||
The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup | Q80682934 | ||
Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis | Q84749218 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1732-1743 | |
P577 | publication date | 2015-01-22 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks | |
P478 | volume | 64 |
Q97644533 | A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions |
Q58566631 | A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin |
Q41325775 | A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. |
Q36694188 | Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis |
Q37421598 | Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism |
Q39606031 | Antibiotic-Associated Apoptotic Enterocolitis in the Absence of a Defined Pathogen: The Role of Intestinal Microbiota Depletion |
Q47130145 | Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice |
Q59796435 | Antibiotic-Induced Dysbiosis of Gut Microbiota Impairs Corneal Nerve Regeneration by Affecting CCR2-Negative Macrophage Distribution |
Q92757722 | Antibiotic-induced dysbiosis of gut microbiota impairs corneal development in postnatal mice by affecting CCR2 negative macrophage distribution |
Q57114440 | Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism |
Q40989594 | Antibiotic-treated versus germ-free rodents for microbiota transplantation studies |
Q36105508 | Antibiotics as deep modulators of gut microbiota: between good and evil. |
Q55072172 | Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients with Cirrhosis. |
Q47141405 | Arsenic exposure and intestinal microbiota in children from Sirajdikhan, Bangladesh |
Q58746178 | Autoprobiotics as an Approach for Restoration of Personalised Microbiota |
Q92374147 | Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host |
Q91625800 | CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont |
Q35561392 | Changing the narrative on antibiotics |
Q91474368 | Commensal microbiota drive the functional diversification of colon macrophages |
Q49185989 | Commensal microbiota modulate gene expression in the skin. |
Q61448787 | Comparative Evaluation of Microbiota Engraftment Following Fecal Microbiota Transfer in Mice Models: Age, Kinetic and Microbial Status Matter |
Q90002880 | Defining Dysbiosis for a Cluster of Chronic Diseases |
Q64255561 | Depletion of Gram-Positive Bacteria Impacts Hepatic Biological Functions During the Light Phase |
Q37595455 | Differentially correlated genes in co-expression networks control phenotype transitions |
Q58777508 | Early Disruption of the Microbiome Leading to Decreased Antioxidant Capacity and Epigenetic Changes: Implications for the Rise in Autism |
Q51143827 | Ecological Restoration of Antibiotic-Disturbed Gastrointestinal Microbiota in Foregut and Hindgut of Cows. |
Q52719208 | Effect of ceftriaxone on the intestinal epithelium and microbiota in neonatal mice |
Q91933372 | Effects of disease, antibiotic treatment and recovery trajectory on the microbiome of farmed seabass (Dicentrarchus labrax) |
Q39455595 | Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation |
Q35961059 | Glyphosate, neurological diseases - and the scientific method |
Q41329575 | Gnotobiotic Human Colon Ex Vivo. |
Q41623268 | Gut Microbial Influences on the Mammalian Intestinal Stem Cell Niche. |
Q39377601 | Gut Microbiome and Bone: to Build, Destroy, or Both? |
Q90294140 | Gut Microbiota and Mucosal Immunity in the Neonate |
Q28066301 | Gut Microbiota: A Contributing Factor to Obesity |
Q46255444 | Gut microbes limit growth in House Sparrows nestlings (Passer domesticus), but not through limitations in digestive capacity |
Q64259059 | Host and microbiome multi-omics integration: applications and methodologies |
Q33575993 | Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice |
Q28068832 | Implication of the intestinal microbiome in complications of cirrhosis |
Q39365350 | Interplay between viruses and bacterial microbiota in cancer development |
Q64123453 | Intestinal Serum amyloid A suppresses systemic neutrophil activation and bactericidal activity in response to microbiota colonization |
Q88916539 | Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models |
Q35958154 | Investigating a holobiont: Microbiota perturbations and transkingdom networks |
Q91283730 | Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet |
Q37686653 | Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification |
Q64986099 | Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis. |
Q57929730 | Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism |
Q33865173 | Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alpha |
Q95839238 | Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus |
Q59133579 | Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria |
Q46353300 | Mucosa-associated microbiota signature in colorectal cancer |
Q44917386 | Multi-omics Comparative Analysis Reveals Multiple Layers of Host Signaling Pathway Regulation by the Gut Microbiota |
Q37583957 | Potential mediators linking gut bacteria to metabolic health: a critical view |
Q33843348 | Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization |
Q38617525 | Regulation of autoimmune myocarditis by host responses to the microbiome. |
Q28083193 | Reverse enGENEering of Regulatory Networks from Big Data: A Roadmap for Biologists |
Q92819148 | Reverse engineering directed gene regulatory networks from transcriptomics and proteomics data of biomining bacterial communities with approximate Bayesian computation and steady-state signalling simulations |
Q92416693 | Role of gut microbiota in type 2 diabetes pathophysiology |
Q36277271 | Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. |
Q50194618 | Segment-specific responses of intestinal epithelium transcriptome to in-feed antibiotics in pigs |
Q91719415 | Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis |
Q49864977 | Sieving through gut models of colonization resistance |
Q64093570 | Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke |
Q95324959 | Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer's transgenic mice |
Q64263858 | The Antibiotic Neomycin Enhances Coxsackievirus Plaque Formation |
Q55416760 | The Presence or Absence of Intestinal Microbiota Affects Lipid Deposition and Related Genes Expression in Zebrafish (Danio rerio). |
Q92705098 | The altered gut virome community in rhesus monkeys is correlated with the gut bacterial microbiome and associated metabolites |
Q26748672 | The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation |
Q35989140 | Thymol and Carvacrol Affect Hybrid Tilapia through the Combination of Direct Stimulation and an Intestinal Microbiota-Mediated Effect: Insights from a Germ-Free Zebrafish Model |
Q64108790 | Tokiinshi, a traditional Japanese medicine (Kampo), suppresses Panton-Valentine leukocidin production in the methicillin-resistant Staphylococcus aureus USA300 clone |
Q46347679 | Topical Antimicrobial Treatments Can Elicit Shifts to Resident Skin Bacterial Communities and Reduce Colonization by Staphylococcus aureus Competitors. |
Q52597757 | Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner. |
Q100465062 | Transcriptional programmes underlying cellular identity and microbial responsiveness in the intestinal epithelium |
Q57301623 | Transkingdom Networks: A Systems Biology Approach to Identify Causal Members of Host-Microbiota Interactions |
Q57191954 | Transkingdom network reveals bacterial players associated with cervical cancer gene expression program |
Q88538044 | Transplantation of human microbiota into conventional mice durably reshapes the gut microbiota |
Q36163200 | Unexpected links reflect the noise in networks. |
Q64355536 | l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans |
Search more.